Literature DB >> 9862158

Thyroid dysfunction in children receiving neck irradiation for Hodgkin's disease.

I L Atahan1, F Yildiz, E Ozyar, D Uzal.   

Abstract

Thyroid function was studied in 46 long-term survivors of pediatric Hodgkin's disease with a median follow-up time of 10.5 years. The mean age of the patients at the time of treatment was 8 years. Treatment consisted of radiotherapy alone in seven patients and combined radiation and chemotherapy in 39 patients. The radiotherapy dose to the thyroid gland was less than 2000 cGy in one, 2000-2500 cGy in 15, 2500-3000 cGy in 17, and greater than 3000 cGy in 13 patients. Evaluation consisted of clinical examination and thyroid function tests of total and free triiodothyronine, thyroxin, arid thyroid stimulating hormone levels. Twenty-one of 46 patients (45.6%) showed thyroid function abnormalities, however only nine of them had diffuse or nodular hyperplasia on physical examination. Risk factors of age, chemotherapy schema, total radiation dose, and dose per fraction did not significantly influence the incidence of thyroid dysfunction.

Entities:  

Mesh:

Year:  1998        PMID: 9862158

Source DB:  PubMed          Journal:  Radiat Med        ISSN: 0288-2043


  3 in total

1.  Hypothyroidism after cancer and the ability to meet reproductive goals among a cohort of young adult female cancer survivors.

Authors:  Helen B Chin; Melanie H Jacobson; Julia D Interrante; Ann C Mertens; Jessica B Spencer; Penelope P Howards
Journal:  Fertil Steril       Date:  2015-10-30       Impact factor: 7.329

2.  Incidence of hypothyroidism after radiotherapy for nasopharyngeal carcinoma.

Authors:  Sükran Ulger; Zekeriya Ulger; Ferah Yildiz; Enis Ozyar
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

3.  Thyroid function and thyroid autoimmunity in childhood acute lymphoblastic leukemia off-therapy patients treated only with chemotherapy.

Authors:  M Delvecchio; V Cecinati; L P Brescia; M F Faienza; D De Mattia; L Cavallo; N Santoro
Journal:  J Endocrinol Invest       Date:  2009-07-28       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.